Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
AMEX
Advisorshares Focused Equity ETF (CWS)
Advisorshares Focused Equity ETF (CWS) Options

Advisorshares Focused Equity ETF (CWS)

67,7762

-0,4738

(-0,69%)

Fermé 06 Juin 10:00PM

68,0902

0,314

(0,46%)

Après les heures de négociation: 1:59AM

Advisorshares Focused Equity ETF ([symbol]) Options

CWS Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
63,00	3,00	6,80	0,00	4,90	0,00	0,00 %	0	0	-
64,00	2,05	5,90	0,00	3,975	0,00	0,00 %	0	0	-
65,00	1,10	4,90	0,00	3,00	0,00	0,00 %	0	0	-
66,00	0,25	4,10	0,00	2,175	0,00	0,00 %	0	0	-
67,00	0,10	3,30	0,00	1,70	0,00	0,00 %	0	0	-
68,00	0,00	2,70	0,00	0,00	0,00	0,00 %	0	0	-
69,00	0,00	2,25	0,00	0,00	0,00	0,00 %	0	0	-
70,00	0,00	2,00	0,00	0,00	0,00	0,00 %	0	0	-
71,00	0,00	1,90	0,00	0,00	0,00	0,00 %	0	0	-
72,00	0,00	1,90	0,00	0,00	0,00	0,00 %	0	0	-
73,00	0,00	1,85	0,00	0,00	0,00	0,00 %	0	0	-

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
63,00	0,00	1,95	0,00	0,00	0,00	0,00 %	0	0	-
64,00	0,00	1,95	0,00	0,00	0,00	0,00 %	0	0	-
65,00	0,00	2,05	0,00	0,00	0,00	0,00 %	0	0	-
66,00	0,00	2,20	0,00	0,00	0,00	0,00 %	0	0	-
67,00	0,00	2,45	0,00	0,00	0,00	0,00 %	0	0	-
68,00	0,00	2,80	0,00	0,00	0,00	0,00 %	0	0	-
69,00	0,00	3,40	0,00	0,00	0,00	0,00 %	0	0	-
70,00	0,40	4,20	0,00	2,30	0,00	0,00 %	0	0	-
71,00	1,30	5,10	0,00	3,20	0,00	0,00 %	0	0	-
72,00	2,30	6,10	0,00	4,20	0,00	0,00 %	0	0	-
73,00	3,30	7,10	0,00	5,20	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

DTGoody

DTGoody il y a 3 minutes

We will be on entirely differently exchange then!

flipper44

flipper44 il y a 4 minutes

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad il y a 4 minutes

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it

Myth

Myth il y a 4 minutes

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence il y a 5 minutes

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts il y a 5 minutes

tisdal

tisdal il y a 6 minutes

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie il y a 7 minutes

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence il y a 11 minutes

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader il y a 11 minutes

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence il y a 12 minutes

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 il y a 12 minutes

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

DewDiligence

DewDiligence il y a 12 minutes

FDA approval of ABT's dual glucose/ketone CGMs is coming soon; the products are already approved in Europe.

1plus1

1plus1 il y a 13 minutes

https://www.theguardian.com/football/2026/jun/06/mexico-security-world-cup-fan-zone-growing-protests-football >> LET'S HOPE THEY MENTION THE CO.

camelion

camelion il y a 16 minutes

June flowers 💐!

Flobewan

Flobewan il y a 16 minutes

Hey, somebody ate all my homemade banana cream ice cream, not only that but they ate all my chocolate/banana cream combo graham cracker crust pie. Now I gotta make more ice cream. Gonna see how chocolate/banana cream ice cream comes out.

And somehow my whole loaf of homemade bread dis

manibiotech

manibiotech il y a 17 minutes

NICE has always said that they are Liaising with NWBO for years . Sommer is know what’s different that you are claiming ?

US Market News

US Market News il y a 17 minutes

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using InsulinJune 6, 2026 2:45 PM
Business Wire Dexcom sponsored CONNECT randomized controlled trial expected to help establish new

joe botts

joe botts il y a 18 minutes

Sorry 6' 1 here! Lol!!!!!!!

manibiotech

manibiotech il y a 18 minutes

Agreed

If they wanted privacy and silence they should have stayed private and not took public money to pay their salaries and development and denied any accountability to the same public ( aka shareholders )

1plus1

1plus1 il y a 18 minutes

world cup starts in days >> biei /security should be involved >>https://www.fifa.com/en/tournaments/mens/worldcup/canadamexicousa2026/mexico/mexico-city

jimr1717

jimr1717 il y a 19 minutes

Has updated timeline 39Z-4 been updated?

researcher59

researcher59 il y a 21 minutes

SPCX - retail shares are not restricted, but Fidelity may limit access to futures IPOs for those who flip their shares in under 15 days.

The IPO may be oversubscribed, so if you ask for 50 shares you might only get 25.

https://www.businessinsider.com/spacex-ipo-fidelity

JimmyRich

JimmyRich il y a 21 minutes

🙏🏼🙏🏼🙏🏼 my friend

Advisorshares Focused Eq...

AdvisorShares Vice

Childrens Place

Parametric Equity Premiu...

Vtion Wireless Technology

BetaShares Capital

Americold Realty

iShares International Ag...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.